Amanote Research
Register
Sign In
The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-0196-03
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 15, 2004
Authors
L. Nici
Publisher
American Association for Cancer Research (AACR)
Related search
Anticancer Activity of Streptochlorin, a Novel Antineoplastic Agent, in Cholangiocarcinoma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Taurolidine: Preclinical Evaluation of a Novel, Highly Selective, Agent for Bone Marrow Purging
Bone Marrow Transplantation
Transplantation
Hematology
Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
PLoS ONE
Multidisciplinary
Malignant Mesothelioma
The Southwest Respiratory and Critical Care Chronicles
Malignant Mesothelioma
British Journal of Cancer
Cancer Research
Oncology
Malignant Cells From Pleural Fluids in Malignant Mesothelioma Patients Reveal Novel Mutations
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances
Oncolytic Virotherapy
Utility of D2-40, a Novel Mesothelial Marker, in the Diagnosis of Malignant Mesothelioma
Modern Pathology
Forensic Medicine
Pathology